Tuesday, September 27, 2022
HomeLatest NewsCovid-19FDA Alerts Providers to COVID-19 Rapid Test Recall

FDA Alerts Providers to COVID-19 Rapid Test Recall

The Food and Drug Administration announced a Class 1 recall of the E25Bio COVID-19 Direct Antigen Response Test. E25Bio is recalling its COVID-19 Direct Antigen Response Tests (DART) for several reasons, particularly that these tests were marketed and distributed to U.S. customers without authorization, clearance, or approval from the FDA. Labeling distributed with some of the tests also includes inaccurate claims and instructions, including a statement that misrepresents the test as FDA-authorized.

Due to the potential for false results, the FDA said health care providers who administered the test in the past two weeks and suspect an inaccurate result should consider retesting patients with an authorized test.

Click here for further details.

Stay Connected

Unified Voice Newsletter

Events This Month

september

27sep11:00 am12:00 pmMinding Time: The Art and Science of Delegation and Prioritizing (Part 2)SDAHO Webinar11:00 am - 12:00 pm Event Type :Education Events,Webinar

29sep11:30 am12:30 pmA Look in the Mirror: Shifting Paradigms to Reduce Racial and Ethnic Disparities in End-Of-Life CareMJHS Hospice and Palliative Care Webinar11:30 am - 12:30 pm Event Type :Education Events,Webinar

29sep12:00 pm1:00 pmUnderstanding CMS Credentialing and Privileging Requirements for Hospitals, CAH and Medicare Advantage OrganizationsSDAHO Webinar12:00 pm - 1:00 pm Event Type :Education Events,Webinar

29sep7:00 pm8:00 pmEffective Communication StrategiesAlzheimer's Association Webinar7:00 pm - 8:00 pm Event Type :Community Events,Education Events

X


By submitting this form, you are consenting to receive marketing emails from: SDAHO, 3708 W Brooks Place, Sioux Falls, SD, 57106, http://sdaho.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact